CD274 and neoplasm: PD-L1 combined positive score (CPS), which calculates the ratio of immunohistochemically PD-L1 positive tumour cells, lymphocytes and macrophages to viable tumour cells, has emerged as a key stratification biomarker for ICI therapy in oesphagogastric patients [47, 48].